MIRA Common Stock Shares Outstanding from 2010 to 2026
| MIRA Stock | 1.23 0.02 1.60% |
Common Stock Shares Outstanding | First Reported 2010-12-31 | Previous Quarter 17.8 M | Current Value 17.2 M | Quarterly Volatility 1.2 M |
Check MIRA Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MIRA Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 181 K, Selling General Administrative of 3.3 M or Selling And Marketing Expenses of 278.5 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.56. MIRA financial statements analysis is a perfect complement when working with MIRA Pharmaceuticals Valuation or Volatility modules.
MIRA | Common Stock Shares Outstanding | Build AI portfolio with MIRA Stock |
Analyzing MIRA Pharmaceuticals's Common Stock Shares Outstanding over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Common Stock Shares Outstanding has evolved provides context for assessing MIRA Pharmaceuticals's current valuation and future prospects.
Latest MIRA Pharmaceuticals' Common Stock Shares Outstanding Growth Pattern
Below is the plot of the Common Stock Shares Outstanding of MIRA Pharmaceuticals Common over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. MIRA Pharmaceuticals' Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MIRA Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Common Stock Shares Outstanding | 10 Years Trend |
|
Common Stock Shares Outstanding |
| Timeline |
MIRA Common Stock Shares Outstanding Regression Statistics
| Arithmetic Mean | 15,333,669 | |
| Geometric Mean | 15,290,728 | |
| Coefficient Of Variation | 8.05 | |
| Mean Deviation | 900,057 | |
| Median | 14,745,170 | |
| Standard Deviation | 1,234,662 | |
| Sample Variance | 1.5T | |
| Range | 3.8M | |
| R-Value | 0.64 | |
| Mean Square Error | 953.4B | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | 157,253 | |
| Total Sum of Squares | 24.4T |
MIRA Common Stock Shares Outstanding History
About MIRA Pharmaceuticals Financial Statements
MIRA Pharmaceuticals stakeholders use historical fundamental indicators, such as MIRA Pharmaceuticals' Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Although MIRA Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in MIRA Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on MIRA Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in MIRA Pharmaceuticals Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 17.8 M | 17.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MIRA Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MIRA Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mira Pharmaceuticals Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mira Pharmaceuticals Common Stock:Check out the analysis of MIRA Pharmaceuticals Correlation against competitors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals. Expected growth trajectory for MIRA significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive MIRA Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding MIRA Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects MIRA's accounting equity. The concept of intrinsic value - what MIRA Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push MIRA Pharmaceuticals' price substantially above or below its fundamental value.
Understanding that MIRA Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MIRA Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, MIRA Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.